PLSE: Pulse Biosciences, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 462.68
Enterprise Value ($M) 412.29
Book Value ($M) 52.15
Book Value / Share 0.95
Price / Book 8.87
NCAV ($M) 37.82
NCAV / Share 0.69
Price / NCAV 12.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.64
Return on Assets (ROA) -0.51
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 9.50
Current Ratio 9.50

Balance Sheet (mrq) ($M)
Current Assets 51.62
Assets 65.94
Liabilities 13.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-15 13D/A Duggan Robert W 68.80 1.39

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 78,450 235,948 33.25
2024-03-27 33,946 57,667 58.87
2024-03-26 28,863 113,873 25.35
2024-03-25 26,614 125,879 21.14

(click for more detail)

Similar Companies
PAVM – PAVmed Inc. PDEX – Pro-Dex, Inc.
PETV – PetVivo Holdings, Inc. POAI – Predictive Oncology Inc.
POCI – Precision Optics Corporation, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Pulse Biosciences